Healthcare & Life Sciences

Speed Variable TDS Operation in X-Ray Imaging Systems

The USPTO granted patent US12599348B2 to GE Precision Healthcare LLC covering TDS (Time-Delayed Summation) acquisition systems in x-ray imaging with variable scan speed capability. The patent (19 claims, filed September 7, 2023) enables constant sampling distance between strobes regardless of scan velocity, producing undistorted images. Inventors include Adam Manders, Michael R. Buchholz, and James Wear.

Visualization of Touch Panel to Object Distance in X-ray Imaging

USPTO granted patent US12599353B2 to Siemens Shanghai Medical Equipment Ltd. on April 14, 2026. The patent covers methods and apparatus for visualizing touch panel to object distance in X-ray imaging, including generating three-dimensional images of detected subjects and creating identifiers to represent distances. The patent contains 18 claims.

Pet Health Radar Monitoring Patent - Franklin Technology

The USPTO granted Patent US12599343B2 to Franklin Technology Inc. on April 14, 2026, covering a radar-based apparatus and method for monitoring pet health status. The invention measures heart rate and breathing rate of pets using radar sensors, detects health abnormalities, and transmits notification messages to pet owners' electronic terminals. The patent includes 7 claims and covers A61B classifications related to physiological measurement.

EU Commission Proposes MDR and IVDR Revision to Simplify Medical Device Rules

The EU Commission published a 170-page proposal on December 16, 2025, revising the Medical Device Regulation (EU) 2017/745 and In Vitro Diagnostic Regulation (EU) 2017/746. The proposal aims to streamline requirements and reduce administrative burden for manufacturers and notified bodies while maintaining public health protection. Key changes include unlimited certificate validity, revised classification rules for surgical instruments and software, relaxed PRRC requirements for small enterprises, and reduced post-market surveillance reporting frequency.

Q&A: Why Data Provenance Is Critical to AI-Powered Drug Discovery

A&O Shearman published a Q&A article examining data provenance considerations for AI-powered drug discovery. The article addresses transaction risks, IP ownership, data usage rights, and regulatory compliance in AI-biotech partnerships. It discusses challenges around patient consent for secondary use of clinical trial data in machine learning training and the importance of understanding where data comes from and under what terms it can be used.

Taking The Pulse Episode 273: Navigating FDA Regulation for Life Sciences Companies

Maynard Nexsen published Episode 273 of its 'Taking The Pulse' healthcare and life sciences video podcast discussing FDA regulatory developments for life sciences companies. The episode features attorney Christin Carey covering tariffs affecting pharma and biotech, evolving FDA guidance for digital health and clinical decision support tools, and the agency's approach to AI, cybersecurity, and emerging technologies.

Two Years On: How UPC Has Impacted European Patent Litigation in Life Sciences

A&O Shearman examines two years of Unified Patent Court (UPC) operations since its June 2023 launch. Over 480 patents have been litigated in the court, with actions steadily increasing. Initially reluctant pharmaceutical players have begun utilizing UPC proceedings, attracted by efficient case management and patentee-friendly decisions. The Court of Appeal has issued harmonizing guidance on key patent validity issues including claim interpretation, inventive step, added matter, sufficiency, and plausibility.

FDA Proposes 20+ Changes Streamlining Biosimilar, Generic Development

The FDA's FY 2027 budget justification includes more than 20 legislative proposals spanning drug and biologic approval pathways, supply chain oversight, and advertising standards. Key provisions include amending Section 351 of the Public Health Service Act to remove the separate statutory standard for biosimilar interchangeability, creating an abbreviated licensure pathway for biological products analogous to the 505(b)(2) pathway, and strengthening supply chain transparency requirements. The FDA has approved 83 biosimilars to date, with 37 approved between January 2024 and January 2026 alone.

National AI Legislative Framework: Healthcare Entity Implications

The White House issued a National Policy Framework for AI on March 20, 2026, calling on Congress to establish a federal policy that preempts state AI laws imposing 'undue burdens.' The Framework has six objectives including protecting children and encouraging AI innovation. No legislation has been passed; current state AI laws (Utah AI Act, Colorado AI Act, California AI amendments) remain in effect. The Framework does not create a new federal rulemaking body—existing agencies like CMS, DOJ, and FDA will continue governing healthcare AI.

Healthcare Sector Targeted in 12% of 2025 Activist Campaigns

Healthcare Sector Targeted in 12% of 2025 Activist Campaigns

DOJ Indicts Osteopathic Physician for Receiving, Selling Misbranded Peptide Drugs

The DOJ indicted a licensed osteopathic physician in Utah for allegedly receiving and selling misbranded drugs from China, marking an escalation in federal peptide enforcement. A Massachusetts medspa owner also pleaded guilty to importing merchandise contrary to law and selling counterfeit drugs and devices. This enforcement wave aligns with the FDA's first warning letter to a clinic regarding unapproved drug sources for aesthetic treatments.

FinCEN Health Care Fraud Advisory and Proposed Whistleblower Rule

FinCEN issued a health care fraud advisory on March 30, 2026, urging financial institutions to identify and report suspicious activity tied to Medicare, Medicaid, and other federal and state health care benefit program fraud, in coordination with the FBI and HHS Office of Inspector General. One day later, FinCEN published a proposed rulemaking to implement its whistleblower incentives and protections program under the Anti-Money Laundering Act of 2020 and AML Whistleblower Improvement Act of 2022.

FY 2027 HHS Budget Proposes Cuts, Restructuring

Holland & Knight LLP summarizes the Trump Administration's FY 2027 HHS Budget released April 3, 2026. The budget proposes targeted funding reductions across federal health programs, structural changes aligned with the Make America Healthy Again (MAHA) agenda, and increased oversight. Major entitlement reforms are notably absent, with the administration potentially pursuing Medicare and Medicaid changes through regulatory or congressional engagement rather than the budget process.

FDA Reversal on Injectable Peptides Creates Investor Risk

Guidepost Solutions analyzes FDA's reversal of its 2023 ban on 14 injectable peptides, including BPC-157, ipamorelin, and Thymosin Alpha-1. The regulatory shift, driven by HHS Secretary Kennedy's advocacy, allows these compounds to return to Category 1 where licensed compounding pharmacies can prepare them under physician prescription. However, FDA's scientific leadership reportedly retains safety concerns including immunogenicity, organ toxicity, and product impurity that drove the original restrictions.

CMS Finalizes Contract Year 2027 Medicare Advantage and Part D Final Rule and Rate Announcement

CMS issued the CY 2027 Medicare Advantage and Part D Final Rule on April 2, 2026, along with the CY 2027 Rate Announcement on April 6, 2026. The Rate Announcement projects a net average increase in MA payments of 2.48%, representing over $13 billion in additional payments to plans. The Final Rule makes significant changes to the Star Ratings system, codifies IRA provisions, refines supplemental benefits regulations, and implements deregulatory measures under Executive Order 14192.

EU Pharma Faces New Environmental Risk Assessment Requirements Under Revised Pharmaceutical Legislation

A&O Shearman analyzes EU environmental and sustainability legislation affecting pharmaceutical manufacturers, including provisional agreements on the Corporate Sustainability Due Diligence Directive and Corporate Sustainability Reporting Directive. The analysis focuses on new environmental risk assessment requirements under revised pharmaceutical legislation that will be integrated into marketing authorization applications, with provisions allowing authorities to refuse, suspend, or revoke marketing authorizations for insufficient ERAs or unaddressed environmental risks.

Nucleic Acid Complexes with Cationic/Anionic Polymers and RNA Molecules

The USPTO published patent application US20260096998A1 for nucleic acid complexes comprising cationic polymers, anionic polymers, and monomeric RNA molecules. The disclosed complexes feature a core structure where the cationic polymer and RNA molecule are encapsulated by the anionic polymer. The application covers linear and non-linear configurations of these complexes for therapeutic uses.

Method and System for Confirmation of Microneedle-Based Analyte-Selective Sensor Insertion via Electrical Interrogation

USPTO granted patent US12599337B1 to Biolinq Incorporated on April 14, 2026, covering a system and method for confirming microneedle sensor insertion into viable tissue using electrical interrogation. The invention applies electrical stimulus between electrodes within an analyte-selective sensor array (200-2000 μm vertical extent) to measure a response and compare it against a reference value to determine insertion success. If insertion fails, the user is instructed to apply additional force or re-apply the sensor.

Non-invasive Assessment of Glymphatic Flow and Neurodegeneration from Wearable Device

USPTO granted patent US12599332B2 to Applied Cognition, Inc. for a computer-implemented method and system that processes neurophysiological and neurovascular data recorded during sleep from wearable devices to assess glymphatic flow and predict neurodegeneration markers. The patent covers function mapping from the recorded data to target markers including glymphatic flow markers, molecular analysis markers, and neuroimaging markers of neurodegeneration. The patent contains 30 claims.

US12599336B2 - Earring-Based Continuous Physiological Monitoring Wearable Device

USPTO granted patent US12599336B2 to inventors Zhang, Liu, Ji, and Fu for a wearable earring device with integrated sensors for continuous physiological monitoring. The apparatus comprises an earring body with a sensor module positioned to collect biological signals at the auricle, including tonoarteriogram (TAG) signals. The patent application was filed November 29, 2022, and the grant issued April 14, 2026, with 9 claims.

Wearable Medical Device Zoneless Arrhythmia Detection Patent

USPTO granted patent US12599330B2 to West Affum Holdings DAC on April 14, 2026. The patent covers wearable medical devices with zoneless arrhythmia detection using a sudden rate change onset algorithm. The invention includes physiological sensors and arrhythmia detection algorithms for patient monitoring.

Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies

USPTO granted patent US12599331B2 to RETISPEC INC. on April 14, 2026, for a non-invasive hyperspectral eye imaging device designed to detect Alzheimer's Disease-associated Tauopathy biomarkers. The device uses spectral reflectance imaging with a fundus camera to identify pathology indicators in retinal tissue.

Deflectable Elongated Guidewire Assembly

USPTO granted patent US12599338B2 to Boston Scientific Medical Device Limited on April 14, 2026 for a deflectable elongated guidewire assembly used in medical procedures. The patent covers a guidewire with a distal segment configured to be selectively maneuvered along an introducer assembly and to transmit tenting force to biological walls. The patent application was filed May 25, 2021 and contains 11 claims.

Devices and Methods for Assessing Pulmonary Status Using Optical Oxygenation Sensing

USPTO granted patent US12599321B2 to Cardiac Pacemakers, Inc. covering devices and methods for assessing pulmonary status using optical oxygenation sensing. The patent claims an oxygenation monitoring device with an optical emitter configured to emit light at wavelengths from 100 nm to 2000 nm and a detector to measure incident light propagating through lung tissue to determine oxygenation status. The patent application (No. 17864907) was filed on July 14, 2022, and contains 17 claims.

Velano Vascular Phlebotomy Through Peripheral IV Catheter Patent

USPTO granted Velano Vascular patent US12599324B2 for systems and methods for phlebotomy through a peripheral IV catheter. The patent covers apparatus including a catheter, introducer with first and second members, locking mechanism, and actuator configured to move the catheter from within the introducer to extending past the peripheral IV line end. The patent has 7 claims and was assigned to Velano Vascular, Inc.

Device for Measuring a Pressure Differential

The USPTO granted patent US12599311B2 to Clinical Technology Limited for a device measuring pressure differentials. The device comprises a tube with a closed insertion portion for body insertion, at least one pressure sensor located in or on the insertion portion, and a processor configured to provide stimulus to the pressure sensor and correlate the response with pressure differential. The pressure sensor may comprise piezoelectric or electrocapacitive materials and may have different resonant frequencies.

Moisture-resistant Electrocardiography Monitor for Wearable Cardiac Diagnostics

USPTO granted patent US12599326B2 to Bardy Diagnostics, Inc. on April 14, 2026. The patent covers a moisture-resistant wearable ECG monitor featuring a flexible extended wear electrode patch and a reusable monitor recorder that snaps into a receptacle on the patch. The monitor is positioned along the sternal midline and is designed to capture P-wave and QRS interval signals for improved cardiac diagnostics.

Withings ECG Measurement Station Cardiac Monitoring Patent

USPTO granted Withings Patent US12599327B2 for an ECG measurement station incorporating control electrodes and a feedback loop circuit for cardiac monitoring. The patent contains 22 claims and lists inventors Jean-Louis Wang and Antoine Merlot. This represents routine patent issuance creating exclusive rights for the assignee with no immediate compliance obligations for other parties.

Health Trackers for Autonomous Targeting of Tissue Sampling Sites

The USPTO granted patent US12599313B2 to inventor Gil Travish on April 14, 2026. The patent covers health tracker devices configured to autonomously target tissue sampling sites using magnetic resonance spectral data. The scanner includes a magnet for field gradients, RF transmitting antenna, and RF sensing antenna to obtain spectral data from predetermined locations within a volume of interest. The patent contains 14 claims and was filed on June 23, 2022.

Implantable Micro-Biosensor and Method for Operating the Same

USPTO granted patent US12599318B2 to Bionime Corporation on April 14, 2026, for an implantable micro-biosensor device. The invention includes a substrate with multiple working electrodes and a counter electrode configured to measure physiological signals and consume interfering substances. The patent contains 11 claims covering the biosensor architecture and operating method.

Micro Analyte Sensor Continuous Monitoring Device

USPTO granted patent US12599320B2 to Medtrum Technologies Inc. on April 14, 2026, covering a micro analyte sensor and continuous analyte monitoring device. The patent includes dual electrode groups operating at different frequencies for analyte detection with redundancy. The patent contains 9 claims.

Measles Exposure Location Confirmed at Centennial Middle School Southeast Portland

Oregon Health Authority and Multnomah County public health officials confirmed a measles exposure location at Centennial Middle School in southeast Portland. Individuals present at the school between April 1-10, 2026 during school hours may have been exposed. Officials are urging potentially exposed individuals to contact their healthcare providers to determine measles immunity based on vaccination record, age, or laboratory evidence.

System and Methods for Connective Tissue Repair Using Scaffolds

The USPTO issued Patent US12599700B2 to The Children's Medical Center Corporation covering methods and devices for repair of torn or ruptured ligaments using scaffold devices. The patent includes 40 claims spanning methods of placement and fixation, notchplasty techniques, and delayed rehabilitation protocols. The invention is classified under CPC codes A61F 2/08 and relates to connective tissue scaffold technology.

Oral Appliance for Use with CPAP Headgear

The USPTO granted patent US12599740B2 to R.I.P., LLC on April 14, 2026, covering an oral appliance designed for use with nasal CPAP masks. Invented by Rob Veis, the patent contains 14 claims and includes an occlusal opening, interproximal protrusions for tooth retention, and a buccal wall to create an intraoral seal. The application was filed on March 8, 2021 (Application No. 17909722).

DPHHS Partners with Imagination Library to Promote Early Literacy for Montana Children

The Montana Department of Public Health and Human Services (DPHHS) announced a partnership with the Imagination Library of Montana to promote early literacy. The Early Childhood and Family Support Division will integrate Imagination Library promotion into existing programs including home visiting, early intervention, maternal health, child care, and WIC. The program currently serves over 29,000 Montana children under age five, approximately half of the eligible population.

Thraustochytrids, Fatty Acid Compositions, and Methods - DSM Assets

USPTO published patent application US20260096578A1 by DSM IP Assets B.V. covering isolated thraustochytrid microorganisms, microbial oils, biomasses, compositions, and associated production and use methods. The application, filed August 13, 2025, lists six inventors and covers CPC classifications spanning food, cosmetic, and pharmaceutical applications.

Microbial Compositions and Methods for Fermented Foods

USPTO published patent application US20260096563A1 for microbial compositions comprising purified populations of microorganisms used in producing dough or baked food products. The compositions are designed to enhance fermentation by improving rheological properties, nutritional quality, and shelf-life of dough and baked food products. The application was filed on December 9, 2025, with inventors Cameron Martino and James Gaffney.

Balloon-type Retinal Stimulation Device and Manufacturing Method - Patent Grant US12599769B2

The USPTO granted Patent US12599769B2 to Daegu Gyeongbuk Institute of Science and Technology for a balloon-type retinal stimulation device. The invention includes a substrate unit with an expandable insertion portion and a stimulation unit that contacts the retina. The device uses fluid injection to expand and conform to the retina's shape for optimal stimulation. The patent contains 10 claims and was filed on September 13, 2023.

Laryngoscope with Physiological Parameter Indicator

USPTO granted patent US12599300B2 to Covidien AG for a laryngoscope system featuring physiological parameter monitoring. The system includes a paired laryngoscope with camera and display that receives physiological data from a monitor, generating visual indicators for healthcare providers during procedures.

Sony Patent for ML-Based Eyesight Test System Using Eye Image Analysis

The USPTO granted Patent US12599303B2 to Sony Group Corporation on April 14, 2026, covering a machine learning-based eyesight test system. The system uses a processor and ML algorithm to estimate eyesight characteristics including myopia, hyperopia, and astigmatism from eye images. The patent application was filed February 28, 2023 and contains 17 claims defining the scope of the invention.

Sensor Device, System, and Method for Performing an Absolute Blood Pressure Measurement

USPTO granted patent US12599308B2 to AIT Austrian Institute of Technology GmbH on April 14, 2026. The patent covers a sensor device or system for performing absolute blood pressure measurements using a finger abutment surface, dual sensors measuring blood volume pulses and force/pressure, and processing circuitry to determine absolute blood pressure. The patent contains 17 claims.

Configurable Hardware Platform for Physiological Monitoring

USPTO granted patent US12599304B2 to Bardy Diagnostics, Inc. for an implantable medical device featuring a configurable hardware platform for physiological monitoring. The device includes electrodes on a hollow housing, a microcontroller with non-volatile memory, an analog front end for ECG signal sensing, wireless transceiver for external data communication, and a receiving coil with charging circuit. The patent contains 19 claims.

Pupil Dynamics Assessment System for Situational Awareness Competency Estimation

USPTO granted patent US12599306B2 to Rockwell Collins, Inc. covering a computer-implemented system and method for assessing operator performance by analyzing eye tracking data correlated with physiological data including heart rate. The system evaluates whether operators exhibit anticipatory responses, differentiates cognitively-initiated behaviors from environmentally-triggered behaviors, and assesses situational awareness competency. The patent contains 16 claims.

System for Conducting Eye Examinations for Visual Acuity

USPTO granted patent US12599301B2 to Verily Life Sciences LLC on April 14, 2026, covering systems and methods for conducting eye examinations to assess visual acuity. The patent describes an optical subsystem positioned in front of one or both eyes of a user, which may be a handheld or head-worn device, capable of determining distance based on comparing a fixed visual indicator size to its detected size in a camera image. The system outputs eye examination images based on valid distance ranges and accepts user input for visual stimulus selection. The patent contains 22 claims.

Amazon Technologies - mmWave Radar Oxygen and Vital Signs Monitoring Patent

The USPTO granted Amazon Technologies Patent US12599307B1 for a method of concurrent monitoring of indoor oxygen concentration levels and human vital signs using mmWave radar sensors. The technology employs triangular and ramp-type chirp signals to detect vital signs such as heart rate and respiratory rate, while RSSI measurements at approximately 60 GHz determine oxygen concentration in the ambient environment. The patent includes 20 claims.

Stretch Layered Sheet, Disposable Wearing Article, and Manufacturing Method and Device

USPTO granted Patent US12599513B2 to ZUIKO CORPORATION on April 14, 2026. The patent covers a stretch layered sheet with thermal bonding between non-woven fabrics and film, featuring vents that provide air permeability in both stretched and non-stretched states. The invention also includes methods and devices for manufacturing the stretch layered sheet.

LG Chem Absorbent Article Patent US12599511B2 Granted

The USPTO granted Patent US12599511B2 to LG Chem, Ltd. on April 14, 2026, covering an absorbent article with a superabsorbent polymer film designed to improve leak prevention in three-dimensional gathers. The patent application (18266063) was filed on May 11, 2022, and includes 6 claims.

Daio Paper Disposable Diaper Patent US12599514B2

USPTO granted Patent US12599514B2 to Daio Paper Corporation on April 14, 2026, covering a disposable diaper design featuring absorber body compression areas for enhanced fit and wearer comfort. The patent includes 7 claims specifying round and oval compressed areas arranged at intervals in the width and front-back directions. This grant gives the assignee exclusive rights to the patented technology.

Kimberly-Clark Absorbent Article with Leak-Proof Containment Flaps

The USPTO granted Patent US12599510B2 to Kimberly-Clark Worldwide, Inc. on April 14, 2026. The patent covers an absorbent article with leak-proof containment flaps bonded using transverse ultrasonic point patterns. The invention restricts fluid leaks between bond lines while maintaining aesthetic appeal. The patent includes 20 claims and names Matthew X Majestic, Lynn Lynch, Janet E. Collins, Austin N. Pickett, Amanda L. Plump, Joseph J. Sina, and Lori A. Roocks as inventors.

US12599508B2 - Absorbent Articles with Frangible Pathways - Procter & Gamble

USPTO granted Patent US12599508B2 to The Procter & Gamble Company covering absorbent articles with elastic laminates and frangible pathways in front and/or back waist regions, along with methods and apparatuses for manufacturing such articles. The patent names eight inventors including Jeffry Rosiak, Michael Devin Long, Jason Edward Naylor, Michael Brian Quade, Matthew Alexander Gittings, Uwe Schneider, Jeromy Thomas Raycheck, and Keith Richard Willhaus. The patent contains 17 claims and was filed on June 27, 2023, under Application No. 18214750.